Seizures during intracarotid METHOHEXITAL (cas 18652-93-2) and amobarbital testing
-
Add time:10/01/2019 Source:sciencedirect.com
BackgroundMETHOHEXITAL (cas 18652-93-2) and amobarbital have been used as agents for Wada testing in the presurgical evaluation of patients with epilepsy. Previous experience with methohexital as an anesthetic indicates that methohexital may decrease seizure threshold and may trigger seizures.
We also recommend Trading Suppliers and Manufacturers of METHOHEXITAL (cas 18652-93-2). Pls Click Website Link as below: cas 18652-93-2 suppliers
Prev:Short communicationLanguage assessment in Wada test: Comparison of METHOHEXITAL (cas 18652-93-2) and amobarbital
Next:The hydroformylation of 4-penten-1-ol and 3-buten-1-ol in water with HRh(CO)(TPPTS)3 and the effects of solution ionic strength) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationLanguage assessment in Wada test: Comparison of METHOHEXITAL (cas 18652-93-2) and amobarbital09/27/2019
- Comparison of METHOHEXITAL (cas 18652-93-2) and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders09/26/2019
- Original ContributionEvaluation of METHOHEXITAL (cas 18652-93-2) as an alternative to propofol in a high volume outpatient pediatric sedation service09/25/2019
- Case ReportPositive pharmacologic provocative testing with METHOHEXITAL (cas 18652-93-2) during cerebral arteriovenous malformation embolization09/24/2019
- METHOHEXITAL (cas 18652-93-2)☆09/10/2019
- Clinical studySuperselective METHOHEXITAL (cas 18652-93-2) challenge prior to intracranial endovascular embolization☆09/09/2019
